CMP as on04-Oct-22 15:58₹ 91.15
Turnover (lac)₹ 2
Prev. Close₹ 91.40
Day's Vol (shares)₹ 14,169
It said API is used as anti-malarial drugs, the company said in an exchange filing.
Anuh Pharma Ltd has informed BSE that it has got approval for Erythromycin Ethyl Succinate and Pyrazinamide by French Naional Agency fo
The company got an approval for Pyrazinamide APIMF158 and Sulfadoxine APIMF234 following inspection on September 16, 2016 by World Heal
Net profit of Anuh Pharma rose 3.21% to Rs 5.14 crore in the quarter ended March 2016 as against Rs 4.98 crore during the previous quar
The World Health Organisation (WHO) has suspended its products Pyrazinamide and Sulfadoxine from prequalified list of active pharmace
The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 159 respectively.
Anuh Pharma Ltd has informed BSE that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxin
European Directorate for the Quality of Medicines (EDQM) Ad Hoc Committee suspended the certificate of suitability for three of the com
The company has received World Health Organization (WHO) Prequalification for the product Sulfadoxine.
The company has announced that it has received World Health Organization (WHO) Prequalification for the product Sulfadoxine.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity